MediciNova signs standby equity purchase agreement for up to $30M

Under the agreement, the company shall have the right, but not the obligation, to sell its common stock in individual transactions – or advances – which will be up to 100% of the daily volume traded of MediciNova’s common stock during the five days immediately before the transaction date.